Sabra Healthcare REIT, Inc. (SBRA) To Go Ex-Dividend on November 14th

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) announced a quarterly dividend on Thursday, November 2nd, NASDAQ reports. Investors of record on Wednesday, November 15th will be given a dividend of 0.07 per share by the real estate investment trust on Thursday, November 30th. This represents a $0.28 dividend on an annualized basis and a yield of 1.48%. The ex-dividend date of this dividend is Tuesday, November 14th.

Shares of Sabra Healthcare REIT (NASDAQ SBRA) traded down $0.55 during trading on Monday, reaching $18.91. 1,408,806 shares of the company’s stock were exchanged, compared to its average volume of 1,577,545. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.66 and a quick ratio of 1.66. Sabra Healthcare REIT has a twelve month low of $19.07 and a twelve month high of $29.10. The firm has a market cap of $3,400.00, a price-to-earnings ratio of 8.54, a price-to-earnings-growth ratio of 2.52 and a beta of 0.94.

WARNING: “Sabra Healthcare REIT, Inc. (SBRA) To Go Ex-Dividend on November 14th” was published by Markets Daily and is owned by of Markets Daily. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this news story can be accessed at https://www.themarketsdaily.com/2017/11/13/sabra-healthcare-reit-inc-sbra-to-go-ex-dividend-on-november-14th.html.

A number of analysts have recently weighed in on the stock. Stifel Nicolaus reiterated a “hold” rating and issued a $26.00 price objective on shares of Sabra Healthcare REIT in a research note on Friday, July 28th. BidaskClub upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Wednesday, July 19th. Zacks Investment Research upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Wednesday, August 2nd. Mizuho upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “neutral” rating and increased their price objective for the stock from $23.00 to $24.00 in a research note on Monday, September 11th. Finally, Bank of America Corporation increased their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock an “underperform” rating in a research note on Friday, September 8th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to the company. Sabra Healthcare REIT presently has a consensus rating of “Hold” and an average price target of $24.40.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Dividend History for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply